CLOSE X

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2143.1032.9 (+1.56 %)
PREV CLOSE ( ) 2110.20
OPEN PRICE ( ) 2112.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4473
TODAY'S LOW / HIGH ( )2099.55 2146.10
52 WK LOW / HIGH ( )2090.1 3050
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 03-07 1991
Management Info
Ramesh Juneja - Chairman Rajeev Juneja - Managing Director
Registered Office

Address 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone 011-46846700 / 47476600

Email contact@mankindpharma.com

Website www.mankindpharma.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
13Nov Mankind Pharma submits analyst meet in
Pursuant to Regulation 30 read with Part A of Schedule III of the Securi..
07Nov Mankind Pharma reports 21% fall in Q2
Mankind Pharma has reported result for second quarter ended September 30..
29Oct Mankind Pharma informs about earnings
Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and..
13Oct Mankind Pharma inks pact to acquire Wo
Mankind Pharma has executed a Business Transfer Agreement (BTA) with its..
08Sep Mankind rises on getting CDSCO’s appro
Mankind Pharma is currently trading at Rs. 2575.55, up by 24.05 points o..
Financials
Rs. in Millions
QTR Sep 25 ANNUAL 25
Net Profit458919454.8
Gross Profit 5246.3 23059.9
Operating Profit 7708.630557.6
Net Sales 26087.894978
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27874.65 (0.77%)
M.Cap ( in Cr)59231.69
Divi's Lab (BSE)
 6380.60 (1.37%)
M.Cap ( in Cr)169384.88
Pfizer (BSE)
 5099.25 (0.99%)
M.Cap ( in Cr)23327.91
Astrazeneca Pharma I (BSE)
 9074.55 (0.54%)
M.Cap ( in Cr)22686.38
Kwality Pharma (BSE)
 999.40 (4.90%)
M.Cap ( in Cr)1037.00
Shareholding Pattern
PROMOTERS 72.67%
MUTUAL FUNDS/UTI 7.78%
NON-INSTITUTION 2.61%
FI/BANKS/INSURANCE 1.77%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data September 2025 Broking Complaints Data September 2025 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.